Summary
  • Multi-target molecules 197
  • Clinical molecules 0
  • Avg pChEMBL 7.1
Top Co-occurrence Targets
Active Molecules (197)
InChIKey pChEMBL Type Targets Clinical
LERCEIGOROJLAY 9.6 IC50 2
POPWPHIGQFWRDK 9.3 IC50 2
MEWSAFKJOGMCKZ 9.2 IC50 2
DFVOOMGEUDYSTE 9.1 IC50 2
WVXFUFQTNVWHME 9.0 IC50 2
RZTKCADKVFEBSP 9.0 IC50 2
TXFALORVHGHNIZ 9.0 Ki 2
GSUNDMAZJLWTIT 8.7 Ki 2
UGXSZZAITMURED 8.7 IC50 2
AWSZFCNWIVMPPT 8.5 Ki 2
LOFFTBAELMOYKZ 8.5 Ki 2
MMVYUHFDLZLNDJ 8.5 IC50 2
QZQMFRGAGVCQAU 8.5 Ki 2
QNLMYJJUQPZSSI 8.5 IC50 2
FBDZPOPZZIODCH 8.4 Ki 2
PXPFKYBINQAOCO 8.4 Ki 2
YFAVHMGYTFULDO 8.4 Ki 2
CJXNCBSSADROTD 8.3 Ki 2
MXEGAMGMDDENAC 8.3 Ki 2
WAXJMBFCXYZEEF 8.3 IC50 2
HSSWPCDEWPTIQS 8.3 IC50 2
ILOODQHBNBJAAG 8.2 IC50 2
ULEIWGQRBVSCTG 8.2 Ki 2
RRGARHLRSSYTCB 8.2 IC50 2
RAAXPKDUFYAXAD 8.2 IC50 2
RHFOTHRIPKQIDW 8.2 IC50 2
ULEIWGQRBVSCTG 8.2 Ki 2
WUMUSTXWZPBYJT 8.2 Ki 2
DDNKJVYYJPDFOE 8.1 IC50 2
QFTTVHGJIGPMTG 8.1 IC50 2
VDPJORBKOLOGMZ 8.1 IC50 2
DAVWSCGJIBGBHZ 8.1 IC50 2
ALCYYDYSILTTKJ 8.1 IC50 2
PDQAUBWJYWYCIF 8.0 IC50 2
KSBJTEAOFRKHIW 8.0 IC50 2
KSSDFKAUXACCMX 8.0 IC50 2
SVOCCYIUNITIHL 8.0 IC50 2
JXGIYKRRPGCLFV 8.0 IC50 2
UOAJBSPQDBHHRC 8.0 IC50 2
LIENCHBZNNMNKG 7.9 IC50 2
SMQQOJDQJBWRCU 7.9 IC50 2
IYZRWOMTSMYRCM 7.9 Ki 2
QJCAWERZKXLFIJ 7.9 Ki 2
FTIFIZZEWIBTMR 7.8 IC50 2
NJXPUSRCRCOWEQ 7.8 IC50 2
QMOLFHLCHURCHA 7.8 IC50 2
UTSXCJSXSSVXHI 7.8 Ki 2
MJZNRHTYZRSATJ 7.8 IC50 2
AQACCMRPIZQLDS 7.8 Ki 2
NFXZAFCZOMISJH 7.7 IC50 2
2D structure